Home › Funds › Invesco Ltd › DNA
Invesco Ltd position in DNA
GINKGO BIOWORKS HOLDINGS INC · Health Care
Latest position (Q2 2026)211.72K sh
Reported value held$2.10M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 26.71K | $217.72K | New |
| Q4 2024 | 26.55K | $260.76K | Reduce |
| Q1 2025 | 93.68K | $534.00K | Add |
| Q2 2025 | 159.81K | $1.80M | Add |
| Q3 2025 | 211.14K | $3.08M | Add |
| Q4 2025 | 261.71K | $2.17M | Add |
| Q1 2026 | 234.81K | $1.44M | Reduce |
| Q2 2026 | 211.72K | $2.10M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DNA
- BlackRock Inc 4.28M sh · $42.44M · Q2 2026
- Viking Global Investors 3.58M sh · $35.45M · Q2 2026
- Vanguard Group 2.90M sh · $24.11M · Q4 2025
- Baillie Gifford & Co 2.39M sh · $23.70M · Q2 2026
- Legal & General Investment Management America 1.67M sh · $16.54M · Q2 2026
- Geode Capital Management 1.22M sh · $12.11M · Q2 2026
- UBS Group AG 691.66K sh · $6.85M · Q2 2026
- Millennium Management 638.68K sh · $6.33M · Q2 2026
- AQR Capital Management 621.62K sh · $6.16M · Q2 2026
- Goldman Sachs Group 607.38K sh · $6.02M · Q2 2026
- Bank of America Corp 545.85K sh · $5.41M · Q2 2026
- Renaissance Technologies 539.86K sh · $5.35M · Q2 2026